Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 49
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
3.
Antibiot Med Biotekhnol ; 32(5): 379-82, 1987 May.
Artigo em Russo | MEDLINE | ID: mdl-3606056

RESUMO

Two hundred and two patients with acute erysipelas and 28 patients in remission of the disease were examined. 102 patients of the main group were treated with sodium nucleinate and levamisole in addition to the routine therapy and 100 patients of the control group were subjected to the routine therapy alone. The favourable effect of the immunomodulators on the clinical picture of the disease and the immune status of the patients was shown.


Assuntos
Antibacterianos/administração & dosagem , Erisipela/tratamento farmacológico , Levamisol/administração & dosagem , Ácidos Nucleicos/administração & dosagem , Penicilina G Benzatina/administração & dosagem , Penicilina G/administração & dosagem , Adulto , Quimioterapia Combinada , Erisipela/imunologia , Erisipela/prevenção & controle , Humanos , Pessoa de Meia-Idade , Recidiva
13.
Zh Mikrobiol Epidemiol Immunobiol ; (11): 93-6, 1985 Nov.
Artigo em Russo | MEDLINE | ID: mdl-2936048

RESUMO

The dynamics of circulating immune complexes (CIC) in comparison with the level of SH-groups of serum deproteinate and other characteristics of cell-mediated and humoral immunity (the reaction of the inhibition of antibodies, the levels of T-cells and their main subpopulations) was studied in 103 erysipelas patients and in 46 persons having had the disease at the acute period of this infection and at the periods between relapses. The elevated levels of CIC and SH-groups of serum deproteinate were found to be directly correlated with the inhibition index. The study showed that, as a rule, in patients with the elevated level of CIC the frequently relapsing form of erysipelas, accompanied by the formation of relative hypersuppressor-type secondary immunodeficiency and by a decrease in the functional activity of dermal macrophages, was observed.


Assuntos
Complexo Antígeno-Anticorpo/imunologia , Erisipela/etiologia , Doença Aguda , Adolescente , Adulto , Idoso , Complexo Antígeno-Anticorpo/análise , Convalescença , Erisipela/imunologia , Humanos , Imunidade Inata , Contagem de Leucócitos , Macrófagos/imunologia , Pessoa de Meia-Idade , Prognóstico , Recidiva , Pele/imunologia , Linfócitos T Auxiliares-Indutores/imunologia , Linfócitos T Reguladores/imunologia
17.
Antibiot Med Biotekhnol ; 30(5): 375-8, 1985 May.
Artigo em Russo | MEDLINE | ID: mdl-4026258

RESUMO

Two hundred and six patients with erysipelas were examined. Of these, 100 patients were subjected to the routine therapy and 106 were additionally treated with methyluracil and prodigiosan. It was noted that the use of methyluracil and prodigiosan in the combined treatment of erysipelas promoted an increase in the efficacy of the antibiotic therapy owing to acceleration of the local inflammation regression and the favourable effect of the treatment on the cell immunity.


Assuntos
Antibacterianos/uso terapêutico , Erisipela/tratamento farmacológico , Polissacarídeos Bacterianos/uso terapêutico , Prodigiozan/uso terapêutico , Uracila/análogos & derivados , Adulto , Quimioterapia Combinada , Erisipela/imunologia , Humanos , Imunidade Celular , Pessoa de Meia-Idade , Uracila/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...